Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

45
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
45

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tumor-selective Mcl1 degradation by AUTAC uncouples antitumor efficacy from cardiotoxicity.

bioRxiv : the preprint server for biology·2026
Same author

When Three Is a Crowd: The Inflammatory Escalade of Triple ICI-Induced Myocarditis.

Journal of cardiovascular pharmacology·2026
Same author

Assessing movement quality in individuals with Duchenne muscular dystrophy utilizing accelerometry: Comparisons with healthy controls.

PLOS digital health·2026
Same author

When Off-Label Ketamine Meets Direct-to-Consumer Telehealth: Liability Risks and Ethical Responsibilities.

Psychiatric services (Washington, D.C.)·2026
Same author

From trials to clinics: investigators' perspectives on translating psychedelic research into clinical care.

Translational behavioral medicine·2026
Same author

Elevated Plasma IL-18 Levels During Chemotherapy Treatment for Breast Cancer, Exercise Capacity, and Physical Activity.

JACC. CardioOncology·2026

Related Experiment Video

Updated: Sep 9, 2025

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice
09:00

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice

Published on: August 2, 2018

8.2K

MYH6-Cre Insertion Accelerates Cardiac Phenotype in Dystrophic D2-mdx Mice.

India K Hawkins1, Trung Phi1, Joshua Mitchell2

  • 1Division of Pediatric Cardiology, Department of Pediatrics, Children's Hospital of Richmond at Virginia Commonwealth University, Richmond, Virginia, USA.

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|August 29, 2025
PubMed
Summary

New Duchenne Muscular Dystrophy (DMD) mouse models show obesity and early death. This research explores fibrosis and cardiac dysfunction, aiming for a more accurate DMD pathology model.

More Related Videos

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

3.7K
Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice
08:13

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice

Published on: April 10, 2019

6.2K

Related Experiment Videos

Last Updated: Sep 9, 2025

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice
09:00

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice

Published on: August 2, 2018

8.2K
Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

3.7K
Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice
08:13

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice

Published on: April 10, 2019

6.2K

Area of Science:

  • Biomedical Science
  • Genetics
  • Cardiology

Background:

  • Duchenne Muscular Dystrophy (DMD) is an X-linked recessive disorder.
  • Dystrophin gene mutations cause progressive muscle weakness and cardiac dysfunction.
  • Current mouse models have limitations in replicating human DMD pathology.

Purpose of the Study:

  • To investigate the phenotype of dystrophin knockout, Cre-positive mice using Myh6cre(Cre) genotypic modification.
  • To assess the potential of this model for studying cardiac pathology in DMD.
  • To evaluate fibrosis and cardiac dysfunction in this novel murine model.

Main Methods:

  • Utilized the Cre/LoxP system for Myh6cre(Cre) genotypic modification in mice.
  • Compared dystrophin knockout, Cre-positive mice with traditional DMD mouse models.
  • Observed and analyzed phenotypes including obesity, premature death, fibrosis, and cardiac dysfunction.

Main Results:

  • Myh6cre(Cre) modified mice exhibited obesity and premature mortality compared to traditional models.
  • Initial observations suggest potential for increased fibrosis and cardiac dysfunction.
  • These findings indicate a distinct phenotype in dystrophin knockout, Cre-positive mice.

Conclusions:

  • The Myh6cre(Cre) genotypic modification may offer a more precise model for studying DMD cardiac pathology.
  • Further research is warranted to fully define the phenotype and utility of this model.
  • This approach could lead to improved preclinical studies for DMD therapeutics.